Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2029-2032

  Harris, Linda C ^a   Remack, Joanna S ^a   Houghton, Peter J ^a   Brent, Thomas P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROETHYLNITROSOUREA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DRUG RESISTANCE; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, P53; GENES, REGULATOR; HUMANS; METHYLTRANSFERASES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS (GENETICS); SUPPRESSION, GENETIC; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029936652     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 6-alkylguanine. FASEB J., 6: 2302-2310, 1992.
2. Day, R S , Ziolkowski, C. H, J., Scudiero, D. A., Meyer, S A , Lubiniecki, A S , Girardi, A J., Galloway, S. M , and Byaum, G D Defective repair of alkylated DNA by human minor and SV40-transformed cell strains. Nature (Lond.), 288: 724-727, 1980
3. 6-alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc. Natl. Acad. Sci USA, 82: 2985-2989, 1985.
4. 6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res., 19: 6163-6167, 1991.
5. 6-methylguanine DNA methyltransferase gene. Nucleic Acids Res., 22: 4614-4619, 1994.
6. Greenblatt, M. S., Bennett, W. P , Hollstein, M., and Hams, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res., 54: 4855-4878, 1994.
7. El-Deiry, W S , Tokino, T., Veculescu, V. E, Levy. D. P , Parsons, R., Trent, J. M., Liu, D., Merrer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75: 817-825, 1993.
8. Miyashita, T , and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293-299, 1995.
9. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes & Dev., 7: 1126-1132, 1993.
10. Zambetti, G. P., and Levine, A. J. A comparison of the biological activities of the wild-type and mutant p53. FASEB J., 7: 855-865, 1993.
11. Doffinger, R., Pawlita, M., and Sczaliel, G Electrotransfection of human lymphoid and myeloid cell lines Nucleic Acids Res., 16: 11840, 1988.
12. Neumann, J R., Morency, C. A., and Russian, K. O. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques, 5: 444-447, 1987.
13. Becker, T C., Noel, R J., Coats, W. S., Gomez-Foix, A M., Alam, T., Gerard, R. D., and Newgard, C B Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43: 161-189, 1994.
14. Sanes, J. R., Rubenstein, J. L., and Nicolas, J. F Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos, EMBO J , 5: 3133-3142, 1986.
15. 6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies. Cancer Res., 50, 58-61, 1990
16. 6-methylguanine-DNA methyltransferase. Carcinogenesis (Lond ), 15. 577-582, 1994.
17. Miyashita, T., Hangai, M., Kanada, M., and Reed, J C. Identification of a p53-dependent negative response element in the bcl-2 gene Cancer Res , 54: 3131-3135, 1994.
18. Deb, S., Jackson, C T., Subler, M. A., and Martin, D. W. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J. Virol., 66: 6164-6170, 1992.
19. Kastan, M. B., Onyinye, O , Sidransky, D., Vogelstein, B , and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
20. - cells Cancer Res., 52 6404-6406, 1992.
21. Felix, C. A., Kappel, C C., Mitsudomi, T., Nau, M. M., Tsokos, M , Crouch, G D Nisen, P. D., Winick, N. J., and Helman, L. J. Frequency and diversity of p53 mutations in childhood rhabdomyosarcomas Cancer Res., 52: 2243-2247, 1992.
22. + human tumor cells Carcinogenesis (Lond.), 16, 2255-2257, 1995.
23. 6-methylguanine-DNA methyltransferase. Proc. Am Assoc. Cancer Res., 32: A2505, 1991
24. Armentrout, S. A., Foltz, E., Vermund, H , and Otis, P. Comparison of postoperative irradiation alone and in combination with BCNU (NSC-409962) m the management of malignant gliomas. Cancer Chemother. Rep., 58: 841-844, 1974.
25. Trovo, M. G., De Paoli, A., Franchin, G., Roncadin, M., Veronesi, A., Tirelli, U , Galligiom, E., Tumolo, S., and Grigoleno, E. Treatment of grade III and IV astrocytoma with high-dose irradiation: schedule and chemotherapy. Am J Clin. Oncol , 7: 265-268, 1984.
26. Pan, Z-Q , Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., and Hurwitz, J. Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol. Chem., 270: 22008-2201;6, 1995.
27. Li, R , Waga, S., Hannon, G. J., Beach, D., and Stillman, B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.), 371: 534-537, 1994